Measurement properties of the Brazilian online version of the Fibromyalgia Rapid Screening Tool (FiRST)

Abstract

Objective The Fibromyalgia Rapid Screening Tool (FiRST) was developed to screen people with chronic pain for Fibromyalgia (FM), especially in primary health care settings. This study aimed to translate the FiRST into Brazilian Portuguese and evaluate its measurement properties for an online application. Methods After the process of translation and backtranslation, the FiRST was applied online in 483 adults with chronic pain (FM group n = 395; Chronic pain group n = 88), along with the Numerical Rating Scale for pain and fatigue, the Brief Pain Inventory, and the Fibromyalgia Impact Questionnaire-Revised. A Receiver Operating Characteristics (ROC) curve was computed and the area under the curve (AUC) was used to determine the sensibility, specificity, and cut-off score for the FiRST. The Mann-Whitney test was used for quantitative variables and the Chi-square and the Fisher’s exact test, for the categorical variables with level of significance of 5%. Fleiss’ Kappa, Gwet’s AC1 and percentage of agreement were also calculated between test and retest. Results For all the questionnaires, the FM group presented higher scores, which mean a worst condition. The FiRST presented a sensitivity of 92.3%, and a specificity of 61.6% with 5 as the cut-off score. AUC, Fleiss’ Kappa, Gwet’s AC1 and percentage of agreement were, respectively, 0.82, 0.38, 0.63 and 71.8%. Conclusion The FiRST was translated into Brazilian Portuguese and the online version presented a good content validity and adequate measurement errors that allow FM patients to be screened among people with chronic pain.

Validation of the Fibromyalgia Rapid Screening Tool in patients with axial spondyloarthritis: Polish version adaptation and value in clinical practice

“…Originally FiRST was developed in French and English and has been translated according to the MAPI Research Trust website into Arabic, German, Greek, Portuguese, Spanish, Turkish, and Ukrainian languages [31]. The linguistic validation (with results available in English) was performed for Arabic [15], Greek [17], Portuguese [16], Spanish [13,14] and Turkish [18] versions. Our Polish version of FiRST compared to other language versions showed slightly lower internal consistency (Cronbach's α = 0.644 vs 0.7-0.787) [13,15,17] and comparable test-retest reliability (ρ = 0.75 vs 0.76-0.875) [15,18].…”

“…In the development study, FiRST showed a sensitivity of 90.5% and a specificity of 85.7% (AUC = 0.93) in diagnosing FM (according to 1990 ACR criteria), while also showing good consistency of the test over time (ICC = 0.87). As of today, FiRST has been translated and validated into several languages, showing good psychometric properties [13][14][15][16][17][18]. However, there is no Polish language version of FiRST.…”

Fibromyalgia Rapid Screening Tool (FiRST): Arabic Translation and Cross-Cultural Adaptation and Validation

“…Apart from the French and the English versions of FiRST [ 22 ], FiRST has been translated according to MAPI Research Trust website into Dutch, Belgium, German, Greek, Italian, Portuguese, Russian, Spanish, Turkish, and Ukrainian languages [ 23 ]. The linguistic validation was not applied to all translations [ 23 ], and limited to the Spanish [ 45 ], Greek [ 46 ], Brazilian [ 47 ], and Turkish [ 48 ] versions. The Arabic translation and validation of the FiRST have not been investigated previously.…”

“…We compared our findings with other validated Spanish [ 45 ], Greek [ 46 ], Brazilian [ 47 ], and Turkish [ 48 ] versions of FiRST. In the Spanish study conducted by Torres and colleagues [ 45 ], participants with suspected FM ( n = 172) were included in the study and were compared to a group of controls (non-FM = 85).…”

“…The Cronbach’s alpha for the internal consistency was 0.79, which is similar to what we reported in the Arabic version; the ICC was also high (0.955). The Brazilian study translated and validated an online version of FiRST on two groups of patients; one group had chronic pain and the other group had confirmed diagnosis of FM [ 47 ]. In addition to the FiRST, multiple surveys assessing pain and fatigue were used.…”